SenesTech's $1.1 Million Revenue Target Puts Its E-Commerce Turnaround And Cash Runway To The Test

SenesTech did something unusual for a company that offered no forward outlook on its last call: it went back to investors with a number. Management now expects third-quarter revenue of roughly $1.1 million, well above the $800,000 the Street had penciled in at the time. That shifts the burden of proof. A company that has spent years asking shareholders to trust a story about fertility-based rodent control now has to deliver a figure it chose itself, while its cash pile keeps shrinking.

Consensus has moved up to meet management, with analysts now looking for about $1.1 million in revenue, a 55% jump from the year-ago quarter and roughly 43% above the $770,000 posted last quarter. With estimates sitting right on the guidance, a merely in-line print would confirm the company's credibility but would not surprise anyone. The bottom line looks less impressive. The Street expects a loss of 31 cents a share, narrower than last quarter's 35-cent loss but wider than the 28-cent loss a year ago. That gap reflects the price of the rebuild: heavier operating spending, new sales hires and the after-effects of leadership turnover.

The heart of the story is e-commerce. Last quarter was the first full period in which SenesTech ran its own Amazon storefront, and in-house Amazon sales leapt to $349,000 from $61,000, pushing total e-commerce to a record $511,000. Subscription and direct-to-consumer revenue also nearly doubled sequentially. The guidance implies that momentum carried into a second full quarter rather than reflecting a one-time restocking pop. Equally important is gross margin, which climbed from 62.5% for fiscal 2025 to a record 73.6%. Holding margins in the low 70s as volume scales would show that the online shift is structurally more profitable. A slip back toward the high 60s would raise questions about promotional spending or channel mix.

Business-to-business sales are the weak flank. Reported B2B revenue fell to $259,000 from $350,000 the prior quarter, though management argued that the core business, excluding one-off orders, grew 11% sequentially. The new sales chief, Jack Karabees, only started full-time on July 1 and said larger deals would take about two more quarters, so a breakout this period is unlikely. What would help is early evidence that the vertical-based sales structure, the newly launched AI-enabled assessment and implementation services, and proof points such as the Texas farm deployment showing about an 80% drop in rodent activity are turning into a pipeline. Further reported B2B declines would undercut the argument that the company is building more than a consumer brand.

Cash may matter more than anything on the income statement. SenesTech ended the second quarter with $5.1 million after burning about $1.7 million, and management sidestepped questions about the timing and size of a capital raise. A similar burn would leave the balance near $3.4 million, so any narrowing of the adjusted EBITDA loss from $1.4 million would carry real weight, as would clarity on financing.

The market has been unconvinced. Shares have fallen about 21% since the last report while the S&P 500 slipped roughly 2%, and at $1.08 the stock trades well below its 200-day moving average of $1.48 and far beneath last quarter's $1.22 to $1.90 range. It has, however, recovered sharply from a post-earnings low of $0.55. Bullish sentiment has cooled to about 53% from nearly 77% ahead of the prior report, suggesting enthusiasm has been tempered by dilution worries.

Ultimately, this report hinges on whether SenesTech can hit its own revenue target with margins intact while showing that burn is moving in the right direction. Delivering all three would argue the turnaround is real; delivering revenue alone would leave funding as the dominant story.

This earnings preview was originally published on Earnings Whispers.

This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.